Outcomes in non-metastatic treatment naive extremity ... - PubMed
In treatment naive patients with non-metastatic osteosarcoma, OGS-12 protocol, a dose-dense, non-HDMTX-based, novel, economic and easy to administer regimen produces comparable …
Outcomes in Treatment-Naïve Patients With Metastatic Extremity ...
Feb 8, 2018 · All consecutive treatment-naïve patients with metastatic osteosarcoma were prospectively treated on the novel OGS-12 protocol consisting of sequential doublets of …
112P Real-world data of OGS-12 protocol on non-metastatic …
A total of 22 patients were treated over 2 years on OGS-12 protocol. The Initial four cycle of chemotherapy were neo-adjuvant therapy. After resection, histopathology reports were …
Outcomes in non-metastatic treatment naive extremity …
Nov 1, 2017 · In treatment naive patients with non-metastatic osteosarcoma, OGS-12 protocol, a dose-dense, non-HDMTX-based, novel, economic and easy to administer regimen produces …
Evolution of novel, low cost, sustainable osteosarcoma care over …
OGS-12 protocol fared better with respect to grade ¾ toxicities; febrile neutropenia (40%), thrombocytopenia (36%), anaemia (51%) with 4(1%) chemo toxic deaths & compliance to …
Outcomes in Treatment-Naïve Patients With Metastatic Extremity ...
Feb 8, 2018 · All consecutive treatment-naïve patients with metastatic osteosarcoma were prospectively treated on the novel OGS-12 protocol consisting of sequential doublets of …
Due to the practical difficulties with HD MTX, OGS 12 protocol, (a non-HD MTX) based 3 drug regimen was developed by Tata Memorial Hospital (TMH). Here, we are presenting a …
Outcomes in Treatment-Naïve Patients With Metastatic ... - PubMed
The novel, low-cost, non-HDMTX-based, dose-dense OGS-12 regimen has shown comparable outcomes to international standards in metastatic osteosarcomas and is worthy of wider …
Ten-year follow-up of outcomes, patterns of care, and ... - PubMed
Conclusions: Homogenous treatment with the OGS-12 and EFT-2001 protocols resulted in internationally comparable long-term outcomes in the cohorts with nonmetastatic and …
Outcomes in non-metastatic treatment naive extremity …
In treatment naive patients with non-metastatic osteosarcoma, OGS-12 protocol, a dose-dense, non-HDMTX-based, novel, economic and easy to administer regimen produces comparable …